BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2022
View Archived Issues
NBL-028: a CLDN6-CD137 bispecific antibody for treating CLDN6-positive tumors
Read More
QL-401 shows improved blood safety and is efficacious against solid and hematologic cancers
Read More
ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models
Read More
Metacrine divulges new HSD17B13 inhibitors
Read More
RaQualia Pharma patents CRF2 receptor antagonists
Read More
LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies
Read More
Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors
Read More
Cullgen identifies new PROTACs
Read More
AstraZeneca presents new PROTACs for cancer
Read More
ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace
Read More
NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers
Read More
Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study
Read More
Virpax reports preclinical PK results for VRP-324 for management of seizures
Read More
PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403
Read More
CIDRAP receives funding to create coronavirus vaccines R&D roadmap
Read More
WVE-004 shows promise for treating C9orf72-associated neurologic disorders
Read More